Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05240027 · ClinicalTrials.gov registry record · NA
To Vape or Not to Vape
A NA study, sponsored by Methodist Health System.
- Terminated
- Registry status
- NA
- Development phase
- 363
- Enrollment target
NCT05240027: Clinical Trial NA study, sponsored by Methodist Health System.
NCT05240027 is a NA study that was terminated before completion, run by Methodist Health System. The registered enrollment target is 363 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05240027, a NA study, was terminated before completion, sponsored by Methodist Health System.
- TERMINATED
- Registry status
- NA
- Development phase
- 363 participants
- Enrollment target
Study Summary
The overall goal of this study is to increase knowledge of vaping and its associated risks. This study will find the patterns of vaping, and how it all started among adolescents. Investigators want to know if students are aware of the serious and long term effects of vaping. This program titled, "To Vape or Not to Vape", will provide education to adolescents and young adults about the potential risk of vaping in an effort to assist with lowering the usage rates within the population. Content will include information about current statistics, potential short-term and long-term side-effects, and healthy alternatives for dealing with stress and peer-pressure. Investigators anticipate that this program will increase this population's knowledge about the risks of vaping products, and deter them from future use of the products. Effectiveness of this program will be measured by pre and post-tests. Investigators believe this program will make at least 50 percent of the participants more aware of the dangers and consequences of vaping, potentially lowering the rates of those participating in this habit while also preventing others from starting.
Primary Outcome
Investigators will obtain the percentage of vape users and their reasons for vaping from information gathered from (per-test questionnaire).
Interventions
- BEHAVIORAL Vape use survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 363 participants |
| Start Date | 2020-03-13 |
| Est. Completion | 2021-02-26 |
| Phase | NA |
Why NCT05240027 stopped before completion
NCT05240027 is an interventional study that assigns participants to a tested intervention. The registered 363 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 1 intervention - of which Vape use survey is the first listed.
NCT05240027 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05240027 about?
NCT05240027 is a clinical study titled "To Vape or Not to Vape". The overall goal of this study is to increase knowledge of vaping and its associated risks. This study will find the patterns of vaping, and how it all started among adolescents. Investigators want to know if students are aware of the serious and long term effects of vaping. This program titled, "To...
What is the current status of trial NCT05240027?
This trial is currently terminated. It is a NA study. The enrollment target is 363 participants. The study started on 2020-03-13. Estimated completion is 2021-02-26.
What interventions are being tested in trial NCT05240027?
The interventions under investigation include: Vape use survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT05240027?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05240027's enrollment target sits among peer trials
363 284th of 2000 higher than 1,717 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06472245 · 363 participants · Phase 3
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
- NCT04510597 · 364 participants · Phase 3
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
- NCT05098132 · 364 participants · Phase 1
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
- NCT05330221 · 364 participants · NA
Project 2: ACHIEVE- HF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI